 CAMBRIDGE, Mass. and NEW YORK, Sept. 06, 2022 GLOBE NEWSWIRE -- Black Diamond Therapeutics, Inc. Nasdaq: BDTX, a precision oncology medicine company pioneering the discovery and development of Master Key therapies, today announced that its President and Chief Executive Officer, David M. Epstein, Ph.D., will present an update on the Companys progress at the H.C. Wainwright 24th Annual Global Investment Conference. The presentation will be available for on-demand viewing beginning Monday, September 12, 2022, starting at 7:00 AM ET. 